Novavax (NVAX) Inventory Average (2022 - 2026)

Novavax's Inventory Average history runs 5 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• In Q1 2026, Inventory Average rose 20.99% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (up 20.99% YoY), while the FY2025 annual figure was $10.1 million, down 59.77% from the prior year.
• Inventory Average was $11.5 million for Q1 2026 at Novavax, down from $12.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $181.5 million in Q2 2022 to a low of $8.7 million in Q4 2024.
• Historically, Inventory Average has averaged $44.1 million across 5 years, with a median of $28.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory Average sank 84.38% in 2024, then soared 44.11% in 2025.
• A 5-year view of Inventory Average shows it stood at $59.6 million in 2022, then declined by 6.57% to $55.6 million in 2023, then tumbled by 84.38% to $8.7 million in 2024, then jumped by 44.11% to $12.5 million in 2025, then fell by 8.19% to $11.5 million in 2026.
• The last three Inventory Average figures came in at $11.5 million (Q1 2026), $12.5 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.